BeOne Medicines Ltd. — Director's Dealing 2019

Nov 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2019-11-13

Reporting Person: Wang Xiaodong (Director, Chair, Scientific Advisory Brd)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-13	Ordinary Shares	J	50	—	Disposed	4903998	Indirect
2019-11-13	Ordinary Shares	A	50	—	Acquired	50	Indirect
2019-11-14	American Depositary Shares	S	800	$191.0325	Disposed	9200	Direct
2019-11-14	American Depositary Shares	S	2500	$192.1929	Disposed	6700	Direct
2019-11-14	American Depositary Shares	S	2200	$193.0416	Disposed	4500	Direct
2019-11-14	American Depositary Shares	S	704	$194.1224	Disposed	3796	Direct
2019-11-14	American Depositary Shares	S	1900	$195.1442	Disposed	1896	Direct
2019-11-14	American Depositary Shares	S	300	$195.8567	Disposed	1596	Direct
2019-11-14	American Depositary Shares	S	100	$196.87	Disposed	1496	Direct
2019-11-15	American Depositary Shares	S	1496	$202.05	Disposed	0	Direct
2019-11-14	American Depositary Shares	S	2605	$193.5669	Disposed	395	Indirect
2019-11-15	American Depositary Shares	S	395	$202.05	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	7460580	Direct
Ordinary Shares	224372	Indirect

Footnotes

F1: These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F2: Pro rata distribution for no value from Wang Investment LLC which is exempt pursuant to Rule 16a-13 and Rule 16a-9.

F3: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held by the spouse of the Reporting Person.

F5: Each American Depositary Share represents 13 Ordinary Shares.

F6: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.50 to $191.42, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.64 to $192.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.67 to $193.41, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.74 to 194.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.74 to $195.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.80 to $195.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.